medigraphic.com
SPANISH

Revista de Gastroenterología de México

Asociación Mexicana de Gastroenterología
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2005, Number 3

<< Back Next >>

Rev Gastroenterol Mex 2005; 70 (3)

Treatment of hepatic encephalopathy with probiotics and prebiotics Cover image:

Bosques-Padilla FJ, Flores-Rendón AR
Full text How to cite this article

Language: Spanish
References: 17
Page: 372-374
PDF size: 46.85 Kb.


Key words:

No keywords

Text Extraction

No Abstract


REFERENCES

  1. Blei A, Cordoba J. Hepatic encephalopathy. Am J Gastroenterol 2001; 96: 1968-76.

  2. Groenweg M, Quero JC, De Bruijn I, et al. Subclinical hepatic encephalopathy impairs daily functioning. Hepatology 1998; 28: 45-9.

  3. Weissenborn K, Ennen JC, Schomerus H, Ruckery N, Hecker H. Neuropsychological characterization of hepatic encephalopathy. J Hepatol 2001; 34: 768-73.

  4. Solga SF. Probiotics can treat hepatic encephalopathy. Med Hypotheses 2003; 61: 307-13.

  5. Bongaerts GPA, Severijnen RSVM. The beneficial antimicrobial effect of probiotics. Med Hypotheses 2001; 56: 174-7.

  6. Bongaerts GPA, Severijnen RSVM. New strategies in antimicrobial therapy. Med Hypotheses 2001; 56: 178-80.

  7. Vogels GD, Van der Drift C. Degradation of purines and pyrimidines. Bacteriol Rev 1977; 40: 403-68.

  8. Bongaerts GPA, Vogels GD. Uric acid degradation by bacillus fastidiosus strains. J Bacteriol 1976; 125: 689-97.

  9. Cherbut C. Motor effects of short-chain fatty acids and lactate in the gastrointestinal tract. Proc Nutr Soc 2003; 62: 95-9.

  10. Gibson GR. Dietary modulation of the human gut microflora using the prebiotics oligofructose and inulin. J Nutr 1999; 129: 1438s-1441s.

  11. Kandler O, Weiss N. Regular, nonsporing gram-positive rods. Genus Lactobacillus. In: Sneath PHA (ed.). Bergey’s manual of systematic bacteriology. Vol. 2. Baltimore, USA: Williams&Wilkins; 1986, p. 1209-34.

  12. Liu Q, Duan ZP, Ha da K, Bengmark S, Kurtovic J, Riordan SM. Symbiotic modulation of gut flora: effect on minimal hepatic encephalopathy in patients with cirrhosis. Hepatology 2004; 39: 1441-9.

  13. Solga SF, Diehl AM. Gut flora-based therapy in liver disease? The liver cares about the gut. Hepatology 2004; 39: 1197-200.

  14. Vilstrup H. Cirrhosis and bacterial infections. Rom J Gastroenterol 2003; 12: 297-302.

  15. Borriello SP, Hammes WP, Holzapfel W, Marteau P, Schrezenmeir J, Vaara M, Valtonen V. Safety of probiotics that contain lactobacilli or bifidobacteria. Clin Infect Dis 2003; 36: 775-80.

  16. Fontanarosa P, Rennie D, DeAngelis C. The need for regulation of dietary supplements-lessons from ephedra. JAMA 2003; 289: 1568-70.

  17. Joint FAO/WHO Working Group Report on Drafting Guidelines for the Evaluation of Probiotics in Food London, Ontario, Canada, April 30 and May 1, 2002.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Gastroenterol Mex. 2005;70